K. Kalbakis

Trastuzumab decreases the incidence of clinical relapses in patients with early breast cancer presenting chemotherapy-resistant CK-19mRNA-positive circulating tumor cells: results of a randomized phase II study

Vasilis Georgoulias, V. Bozionelou, Sofia Agelaki et al. · Annals of Oncology · 2012 · 147 citations · Full text

Tumor Biology, Breast Oncology, Early Breast Cancer +9

Salvage chemotherapy in anthracycline-pretreated metastatic breast cancer patients with docetaxel and gemcitabine: A multicenter phase II trial

Dimitriοs Mavroudis, Nikolaos Malamos, A. Alexopoulos et al. · Annals of Oncology · 1999 · 94 citations · Full text

Salvage Chemotherapy, Breast Oncology, Oncology +6

Cytoreductive Surgery and Intraoperative Hyperthermic Intraperitoneal Chemotherapy with Paclitaxel: A Clinical and Pharmacokinetic Study

Eelco de Bree, Hilde Rosing, D. Filis et al. · Annals of Surgical Oncology · 2008 · 73 citations

Cytoreductive Surgery, Surgical Oncology, Medicine +7

High incidence of pulmonary toxicity of weekly docetaxel and gemcitabine in patients with non-small cell lung cancer: results of a dose-finding study

Charalambos Kouroussis, Dimitris Mavroudis, Stylianos Kakolyris et al. · Lung Cancer · 2004 · 66 citations

Oncology, Pharmacology, Weekly Docetaxel +7

Cancer cachexia syndrome and clinical outcome in patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors: results from a prospective, observational study

Konstantinos Rounis, Dimitrios Makrakis, Alexandros-Pantelis Tsigkas et al. · Translational Lung Cancer Research · 2021 · 43 citations · Full text